Literature DB >> 9154298

Cytomegalovirus immediate early genes upregulate interleukin-6 gene expression.

G K Iwamoto1, S A Konicek.   

Abstract

BACKGROUND: The immediate early genes (IE) of human cytomegalovirus (CMV) can be expressed in monocytic cells and are known to regulate viral and cellular genes. Interleukin-6 (IL-6) plays a central role in numerous inflammatory and immune processes. Interleukin-6 levels are increased in lung transplant patients clinically diagnosed with CMV pneumonitis. The regulation of IL-6 is dependent on various stimuli that include lipopolysaccharide (LPS), viruses, and other cytokines. These studies examined the ability of CMV IE gene products to modulate IL-6 production.
METHODS: THP-1 cells, a monocytic cell line, were transfected with the CMV IE genes. Interleukin-6 protein and IL-6 mRNA were measured in control and CMV immediate early transfected cells. Cotransfection of CMV IE genes and IL-6 chloramphenicol acetyl transferase (CAT) or IL-6 luciferase constructs were used to study IL-6 promoter activity.
RESULTS: Interleukin-6 protein and mRNA production were significantly increased in cells transfected with the CMV IE genes and stimulated with LPS compared to LPS-stimulated control cells. Cytomegalovirus IE gene products significantly enhanced LPS stimulation of IL-6 promoter activity in both IL-6 CAT and IL-6 luciferase assays. A deletion construct that contains a NF-kappa B site but is missing the multiple response region demonstrated a continued increase in IL-6 luciferase activity in LPS-stimulated CMV transfected cells.
CONCLUSION: Cytomegalovirus immediate early gene products significantly enhanced expression of IL-6 in LPS-stimulated cells. The increase in IL-6 luciferase activity occurs in the absence of the multiple response region, the area of the IL-6 promoter responsive to IL-1, TNF alpha, cyclic amp, and phorbol 12-myristate 13-acetate. The ability of CMV IE gene products to enhance IL-6 production may play an important role in immune inflammatory states associated with CMV infection.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9154298

Source DB:  PubMed          Journal:  J Investig Med        ISSN: 1081-5589            Impact factor:   2.895


  14 in total

Review 1.  Partners in Crime: The Role of CMV in Immune Dysregulation and Clinical Outcome During HIV Infection.

Authors:  Michael L Freeman; Michael M Lederman; Sara Gianella
Journal:  Curr HIV/AIDS Rep       Date:  2016-02       Impact factor: 5.071

2.  Persistent Cytomegalovirus Infection in Amniotic Membranes of the Human Placenta.

Authors:  Takako Tabata; Matthew Petitt; June Fang-Hoover; Martin Zydek; Lenore Pereira
Journal:  Am J Pathol       Date:  2016-09-13       Impact factor: 4.307

Review 3.  Current Understanding of Cytomegalovirus Reactivation in Critical Illness.

Authors:  Hannah Imlay; Ajit P Limaye
Journal:  J Infect Dis       Date:  2020-03-05       Impact factor: 5.226

Review 4.  CMV in critically ill patients: pathogen or bystander?

Authors:  Ajit P Limaye; Michael Boeckh
Journal:  Rev Med Virol       Date:  2010-11       Impact factor: 6.989

5.  Rudimentary signs of immunosenescence in Cytomegalovirus-seropositive healthy young adults.

Authors:  James E Turner; John P Campbell; Kate M Edwards; Lauren J Howarth; Graham Pawelec; Sarah Aldred; Paul Moss; Mark T Drayson; Victoria E Burns; Jos A Bosch
Journal:  Age (Dordr)       Date:  2013-07-12

6.  Human cytomegalovirus induces TLR4 signaling components in monocytes altering TIRAP, TRAM and downstream interferon-beta and TNF-alpha expression.

Authors:  Kok-Hooi Yew; Cory Carpenter; R Scott Duncan; Christopher J Harrison
Journal:  PLoS One       Date:  2012-09-07       Impact factor: 3.240

7.  HCMV activates the IL-6-JAK-STAT3 axis in HepG2 cells and primary human hepatocytes.

Authors:  Quentin Lepiller; Wasim Abbas; Amit Kumar; Manoj K Tripathy; Georges Herbein
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

8.  Human cytomegalovirus IE1 protein elicits a type II interferon-like host cell response that depends on activated STAT1 but not interferon-γ.

Authors:  Theresa Knoblach; Benedikt Grandel; Jana Seiler; Michael Nevels; Christina Paulus
Journal:  PLoS Pathog       Date:  2011-04-14       Impact factor: 6.823

9.  Cellular and molecular mechanisms that mediate basal and tumour necrosis factor-alpha-induced regulation of myosin light chain kinase gene activity.

Authors:  Dongmei Ye; Thomas Y Ma
Journal:  J Cell Mol Med       Date:  2008-03-14       Impact factor: 5.310

10.  Detection of human cytomegalovirus and epstein-barr virus in coronary atherosclerotic tissue.

Authors:  Ana Vitória Imbronito; Silvia Linardi Marcelino; Sabrina Rosa Grande; Fabio Daumas Nunes; Giuseppe Alexandre Romito
Journal:  Braz J Microbiol       Date:  2010-09-01       Impact factor: 2.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.